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Purpose: Chitosan-based implants can stimulate revascularization 
and repair of subchondral trabecular bone damaged by microfracture 
in marrow stimulation therapy. The purpose of this study was to test 
whether chitosan scaffold alone could promote in vitro osteogenesis 
and angiogenic cytokine production by human bone marrow stromal 
cells (hBMSC). 
Methods and Materials: $PO¿VFOUNPOPMBZFSTPGQSJNBSZI#.4$
from healthy donors (n=3, passage 3 to 5) were cultured for 2 to 3 
weeks in osteogenic media with or without 10 nM dexamethasone. 
Half of the cultures received 5 µg/mL chitosan or rhodamine-labeled 
chitosan as free precipitates, twice weekly with each media change. 
Cell monolayers were characterized for proliferation, osteoblast 
differentiation and matrix mineralization, while conditioned media 
XBT BOBMZ[FE CZ QSPUFPNJDT GPS  EJGGFSFOU JO¿BNNBUPSZ BOE
angiogenic factors. 
Results: Dexamethasone suppressed cell proliferation and induced 
alkaline phosphatase and matrix mineralization, possibly because 
EFYBNFUIBTPOFTQFDJ¾DBMMZTVQQSFTTFEUIFTFDSFUJPOPG7&('BOE
BIPTUPGJO¿BNNBUPSZGBDUPSTUIBUXFSFDPOTUJUVUJWFMZTFDSFUFECZ
hBMSC. Among 29 cytokines, the sole effect of chitosan was increased 
MCP-1 and G-CSF. Despite the fact that rhodamine-labeled chitosan 
was detected intra- and extracellularly, chitosan had no effect cell 
proliferation or collagen accumulation, although increased alkaline 
phosphatase activity was observed in some cultures. Extracellular 
chitosan deposits were mutually exclusive of mineralized collagen. 
Conclusions: Bone marrow stromal cells produce high levels 
PG JO¿BNNBUPSZ DZUPLJOFT UIBU DPVME JO¿VFODF UIF USBCFDVMBS
microenvironment during marrow-based cartilage repair. Chitosan 
deposits impeded in vitro bone formation. Our data suggest that 
chitosan enhances marrow-based cartilage repair in vivo indirectly 
by recruiting wound repair macrophages. 
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Purpose: The goal of the present study was to examine the entire 
repair tissue resulting from marrow-stimulating techniques and to 
compare with the surrounding original cartilage using histological 
scores, immunohistochemistry and biochemical parameters. 
Methods and Materials: Repair tissue from marrow-stimulating 
techniques (microfracture and Pridie drilling) of 5 patients with a 
mean age of 57 years and with a mean follow-up of 1.5 years was 
evaluated by polarized light microscopy, histology (H&E, Safranin-
O, PAS-Alcian, van Gieson), immunohistochemistry (Anti-type-I-,II-
,X-collagen), polarization microscopy, biochemistry (proteoglycan: 
DMMB; DNA content: Hoechst 33258) as well as by established 
systems of cartilage repair (ICRS, Sellers, Mankin score) and 
compared with the surrounding articular cartilage. 
Results: Complete articular cartilage regeneration was present in 
none of the cases examined. The repair tissue exhibited histological 
BOE JNNVOPIJTUPDIFNJDBM DIBSBDUFSJTUJDT PG ¾CSPDBSUJMBHF "
tidemark was always missing. Type-II collagen was mainly present. 
The proteoglycan content per dry weight was mostly higher than 
in the adjacent cartilage. The new tissue was always more cell-rich 
(DNA/dry weight) than the adjacent neighboring cartilage. 
Conclusions: Although the tissue was collected from failed cartilage 
repair procedures, the data from the present study support the 
hypotheses that the repair tissue following marrow-stimulating 
techniques exhibits histological and biochemical characteristics 
PG ¾CSPDBSUJMBHF BOE JT GSPN WBSJBCMF RVBMJUZ 5IF CBMBODF PG DFMM
number/extracellular matrix is shifted towards an increased cell 
number. An strategy to promote articular cartilage repair could be 
therefore the stimulation of extracellular matrix production. 
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Purpose: A failed microfracture procedure in the knee presents a 
EJG¾DVMUQSPCMFN5IFQVSQPTFPG UIJT TUVEZXBT UPEFUFSNJOF UIF
outcome following revision microfracture in order to assist patients 
with making an informed decision about which cartilage repair 
method to pursue. . 
Methods and Materials: 45 patients (46 knees) underwent revision 
microfracture between 1992-2004. Procedures were performed 
by a single surgeon at one center. Patients followed a protected 
weightbearing rehabilitation regimen which included continuous 
passive motion. Locations of lesions which underwent revision 
microfracture included 6 lateral femoral condyle, 4 lateral tibial 
plateau, 12 medial femoral condyle, 5 medial tibial plateau, and 18 
trochlear groove lesions. Statistical analysis was performed using 
the paired T-test. 
Results: Average time to revision was 649 days (30-2103). Average 
QSFPQ-ZTIPMNTDPSFQSJPSUP¾STUNJDSPGSBDUVSFXBT	SBOHF
89). Average pre-op Lysholm score prior to revision procedure was 
66(22-86). Average Lysholm score after revision procedure was 75 
(25-100). Follow-up was at least 2 years for all patients. Patients‘ 
-ZTIPMNTDPSF TJHOJ¾DBOUMZ JNQSPWFECFUXFFO UIFQSFPQ SFWJTJPO
and post-op revision microfracture (p <0.05). Trochlear groove 
lesions were associated with the highest Lysholm scores (80) versus 
femoral (70) and tibial (66). 
Conclusions: Patient function improved following revision 
microfracture in the knee. More clinical data is needed to determine 
the value of revision microfracture 
P31
)PXMPOHEPCFOF¾DJBMFGGFDUTPGQBSUJBMNFOJTDFDUPNZQFSTJTU 
K.K. Briggs1, W.G. Rodkey2, J..R. Steadman3;
1Clinical Research, Steadman Hawkins Research Foundation, Vail, 
CO, United States of America, 2Basic Science, Steadman Hawkins 
Foundation, Vail, CO, United States of America, 3Clinical Research, 
Steadman Hawkins Reserach Foundation, Vail, Colorado, United 
States of America
Purpose: Meniscectomy is the current standard of care for the torn 
meniscus not suitable for repair. The purpose of this study was to 
determine how long improvements in function and activity levels 
following meniscectomy would last. 
Methods and Materials: LOFFTXFSF JEFOUJ¾FE GSPNBDMJOJDBM
database. 193 knees had partial lateral meniscectomy, 342 had 
partial medial meniscectomy, and 105 had partial medial and lateral 
meniscectomy. The average age was 52 years (range 15 to 79) 
(207 females and 433males). Patients were excluded if they had 
concurrent ACL reconstructions or microfacture. Lysholm function 
and Tegner activity scores were collected. 
Results: Tegner activity scores improved from preoperative (3.0) 
to one year postoperative (4.5) (p<0.001). This improvement was 
maintained at years 2, 3, and 4. There was no difference between 
preoperative Tegner and year 5, 6, 7, and 8 Tegner scores (p>0.05). 
Lysholm scores improved from preoperative (54) to one year 
postoperative (75) (p<0.001). The Lysholm score did not change 
from year 1 to year 5. At year 6 it decreased to 68 and by year 8 it was 
63 (p values???). Patients with chronic knee injuries returned to their 
preoperative activity level and Lysholm score at 4 years. 
Conclusions: Patients who undergo partial meniscectomy can 
expect on average 4 years of improved function and activity levels. 
Knee function continues to improve up to 4 years, but it decreases 
as activity levels decrease. Patients with chronic knees experience 
the decreases at an earlier time point. Meniscectomy provides short 
term improvement in function and activity levels, but long term 
improvement seems unlikely.
